<div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Projection neurons in the brain that synthesize and release dopamine</div>
<p><b>Dopaminergic pathways</b>, (dopamine pathways, dopaminergic projections) in the human brain are involved in both physiological and behavioral processes including movement, cognition, executive functions, reward, motivation, and neuroendocrine control.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup> Each pathway is a set of <a href="/wiki/Projection_neuron" class="mw-redirect" title="Projection neuron">projection neurons</a>, consisting of individual <b>dopamine neurons</b>.  
</p><p>
There are four major dopaminergic pathways: </p><div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Dopaminergic_pathways.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Dopaminergic_pathways.svg/220px-Dopaminergic_pathways.svg.png" decoding="async" width="220" height="151" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Dopaminergic_pathways.svg/330px-Dopaminergic_pathways.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Dopaminergic_pathways.svg/440px-Dopaminergic_pathways.svg.png 2x" data-file-width="446" data-file-height="307" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Dopaminergic_pathways.svg" class="internal" title="Enlarge"></a></div>The main dopaminergic pathways of the human brain.</div></div></div><p>· &#160; &#160; &#160; The <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a>,
</p><p>· &#160; &#160; &#160; The <a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">mesocortical pathway</a>,
</p><p>· &#160; &#160; &#160; The <a href="/wiki/Nigrostriatal_pathway" title="Nigrostriatal pathway">nigrostriatal pathway</a> and
</p><p>· &#160; &#160; &#160; The <a href="/wiki/Tuberoinfundibular_pathway" title="Tuberoinfundibular pathway">tuberoinfundibular pathway</a>.
</p><p>Other dopaminergic pathways include the <a href="/wiki/Hypothalamospinal_tract" title="Hypothalamospinal tract">hypothalamospinal tract</a> and the <a href="/wiki/Incertohypothalamic_pathway" title="Incertohypothalamic pathway">incertohypothalamic pathway</a>.
</p><p><a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>, <a href="/wiki/Attention_deficit_hyperactivity_disorder" title="Attention deficit hyperactivity disorder">attention deficit hyperactivity disorder</a> (ADHD), <a href="/wiki/Substance_abuse_disorders" class="mw-redirect" title="Substance abuse disorders">substance abuse disorder</a> (<a href="/wiki/Addiction" title="Addiction">addiction</a>), and <a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome (RLS)</a> can be attributed to dysfunction in specific dopaminergic pathways.  
</p><p>The dopamine neurons of the dopaminergic pathways synthesize and release the <a href="/wiki/Neurotransmitter" title="Neurotransmitter">neurotransmitter</a> <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>.<sup id="cite_ref-urlBeyond_the_Reward_Pathway_2-0" class="reference"><a href="#cite_note-urlBeyond_the_Reward_Pathway-2">&#91;2&#93;</a></sup><sup id="cite_ref-projection_3-0" class="reference"><a href="#cite_note-projection-3">&#91;3&#93;</a></sup>&#160;Enzymes tyrosine hydroxylase and dopa decarboxylase, are required for dopamine synthesis.<sup id="cite_ref-Harsing_2000_4-0" class="reference"><a href="#cite_note-Harsing_2000-4">&#91;4&#93;</a></sup> These enzymes are both produced in the <a href="/wiki/Soma_(biology)" title="Soma (biology)">cell bodies</a> of dopamine neurons. Dopamine is stored in the cytoplasm and vesicles in axon terminals. Dopamine release from vesicles is triggered by action potential propagation-induced membrane depolarization.<sup id="cite_ref-Harsing_2000_4-1" class="reference"><a href="#cite_note-Harsing_2000-4">&#91;4&#93;</a></sup> The <a href="/wiki/Axon" title="Axon">axons</a> of dopamine neurons extend the entire length of their designated pathway. 
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Pathways"><span class="tocnumber">1</span> <span class="toctext">Pathways</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Function"><span class="tocnumber">2</span> <span class="toctext">Function</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Mesocorticolimbic_projection"><span class="tocnumber">2.1</span> <span class="toctext">Mesocorticolimbic projection</span></a>
<ul>
<li class="toclevel-3 tocsection-4"><a href="#Mesocortical_pathway"><span class="tocnumber">2.1.1</span> <span class="toctext">Mesocortical pathway</span></a></li>
<li class="toclevel-3 tocsection-5"><a href="#Mesolimbic_pathway"><span class="tocnumber">2.1.2</span> <span class="toctext">Mesolimbic pathway</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-6"><a href="#Cortico-basal_ganglia-thalamo-cortical_loop"><span class="tocnumber">2.2</span> <span class="toctext">Cortico-basal ganglia-thalamo-cortical loop</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Regulation"><span class="tocnumber">3</span> <span class="toctext">Regulation</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#See_also"><span class="tocnumber">4</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Notes"><span class="tocnumber">5</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Pathways">Pathways <span class="anchor" id="Mesocorticolimbic_projection"></span></span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=1" title="Edit section: Pathways">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Six of the dopaminergic pathways are listed below.
</p>
<div style="clear:both;"></div>
<table class="wikitable">
<tbody><tr>
<th scope="col" colspan="2">Pathway name
</th>
<th scope="col">Description
</th>
<th scope="col">Associated processes
</th>
<th scope="col">Associated disorders
</th></tr>
<tr>
<td rowspan="2" style="text-align:center;">Mesocorticolimbic<br />projection
</td>
<td><center><a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">Mesolimbic<br />pathway</a></center>
</td>
<td>The mesolimbic pathway transmits dopamine from the <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">ventral tegmental area</a> (VTA), which is located in the <a href="/wiki/Midbrain" title="Midbrain">midbrain</a>, to the <a href="/wiki/Ventral_striatum" class="mw-redirect" title="Ventral striatum">ventral striatum</a>, which includes both the <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> and <a href="/wiki/Olfactory_tubercle" title="Olfactory tubercle">olfactory tubercle</a>.<sup id="cite_ref-Dopaminergic_pathways_and_reward_system_review_5-0" class="reference"><a href="#cite_note-Dopaminergic_pathways_and_reward_system_review-5">&#91;5&#93;</a></sup><sup id="cite_ref-NHM_pathways_6-0" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup> The "meso" <a href="/wiki/Prefix_(linguistics)" class="mw-redirect" title="Prefix (linguistics)">prefix</a> in the word "mesolimbic" refers to the midbrain, or "middle brain", since "meso" means "middle" in <a href="/wiki/Greek_language" title="Greek language">Greek</a>.
</td>
<td>
<ul><li><a href="/wiki/Reward_system" title="Reward system">reward</a>-related cognition
<ul><li><a href="/wiki/Incentive_salience" class="mw-redirect" title="Incentive salience">incentive salience</a> ("wanting")</li>
<li><span class="nowrap"><a href="/wiki/Pleasure" title="Pleasure">pleasure</a> ("liking") response from certain stimuli</span></li>
<li><a href="/wiki/Positive_reinforcement" class="mw-redirect" title="Positive reinforcement">positive reinforcement</a></li></ul></li>
<li>aversion-related cognition</li></ul>
</td>
<td>
<ul><li><a href="/wiki/ADHD" class="mw-redirect" title="ADHD">ADHD</a></li>
<li><a href="/wiki/Addiction" title="Addiction">addiction</a></li>
<li><a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a></li></ul>
</td></tr>
<tr>
<td><center><a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">Mesocortical<br />pathway</a></center>
</td>
<td>The mesocortical pathway transmits dopamine from the VTA to the <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">prefrontal cortex</a>.  The "meso" prefix in "mesocortical" refers to the VTA, which is located in the midbrain, and "cortical" refers to the cortex.
</td>
<td>
<ul><li><a href="/wiki/Executive_function" class="mw-redirect" title="Executive function">executive functions</a></li></ul>
</td>
<td>
<ul><li><a href="/wiki/ADHD" class="mw-redirect" title="ADHD">ADHD</a></li>
<li><a href="/wiki/Addiction" title="Addiction">addiction</a></li>
<li><a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a></li></ul>
</td></tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/Nigrostriatal_pathway" title="Nigrostriatal pathway">Nigrostriatal pathway</a>
</td>
<td>The nigrostriatal pathway transmits dopamine from the <a href="/wiki/Substantia_nigra_pars_compacta" class="mw-redirect" title="Substantia nigra pars compacta">substantia nigra pars compacta</a> (SNc) to the <a href="/wiki/Caudate_nucleus" title="Caudate nucleus">caudate nucleus</a> and <a href="/wiki/Putamen" title="Putamen">putamen</a>.  The <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> is located in the midbrain, while both the caudate nucleus and putamen is located in the <a href="/wiki/Dorsal_striatum" class="mw-redirect" title="Dorsal striatum">dorsal striatum</a>.
</td>
<td>
<ul><li>motor function</li>
<li><a href="/wiki/Reward_system" title="Reward system">reward</a>-related cognition</li>
<li><a href="/wiki/Associative_learning" class="mw-redirect" title="Associative learning">associative learning</a></li></ul>
</td>
<td>
<ul><li><a href="/wiki/Addiction" title="Addiction">addiction</a></li>
<li><a href="/wiki/Chorea" title="Chorea">chorea</a></li>
<li><a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's&#160;disease</a></li></ul>
</td></tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/Tuberoinfundibular_pathway" title="Tuberoinfundibular pathway">Tuberoinfundibular pathway</a></td>
<td>The tuberoinfundibular pathway transmits dopamine from the <a href="/wiki/Arcuate_nucleus" title="Arcuate nucleus">arcuate nucleus</a> (aka "infundibular nucleus") of the <a href="/wiki/Hypothalamus" title="Hypothalamus">hypothalamus</a> to the <a href="/wiki/Pituitary_gland" title="Pituitary gland">pituitary gland</a> via dopamine release into the <a href="/wiki/Median_eminence" title="Median eminence">median eminence</a> and subsequent circulation through the <a href="/wiki/Hypophyseal_portal_system" title="Hypophyseal portal system">hypophyseal portal system</a>.  This pathway influences the secretion of certain <a href="/wiki/Hormone" title="Hormone">hormones</a>, including <a href="/wiki/Prolactin" title="Prolactin">prolactin</a>, from the pituitary gland.  "Infundibular" in the word "tuberoinfundibular" refers to the cup or <a href="/wiki/Pituitary_stalk" title="Pituitary stalk"><i>infundibulum</i></a>, out of which the pituitary gland develops.
</td>
<td>
<ul><li>activity of this pathway inhibits the release of prolactin.</li></ul>
</td>
<td>
<ul><li><a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">hyperprolactinaemia</a></li></ul>
</td></tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/Hypothalamospinal_tract" title="Hypothalamospinal tract">Hypothalamospinal tract</a></td>
<td>This pathway influences locomotor networks in the brainstem and spinal cord.
</td>
<td>
<ul><li>motor function.</li></ul>
</td>
<td>
<ul><li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">restless legs syndrome</a></li></ul>
</td></tr>
<tr>
<td colspan="2" style="text-align:center;"><a href="/wiki/Incertohypothalamic_pathway" title="Incertohypothalamic pathway">Incertohypothalamic pathway</a></td>
<td>This pathway from the <a href="/wiki/Zona_incerta" title="Zona incerta">zona incerta</a> influences the hypothalamus and locomotor centers in the brainstem.
</td>
<td>
<ul><li>visceral and sensorimotor activities.</li></ul>
</td>
<td>
<ul><li><a href="/wiki/Tremor" title="Tremor">tremor</a></li></ul>
</td></tr></tbody></table>
<p><b>Major pathways</b><sup id="cite_ref-Dopaminergic_pathways_and_reward_system_review_5-1" class="reference"><a href="#cite_note-Dopaminergic_pathways_and_reward_system_review-5">&#91;5&#93;</a></sup><sup id="cite_ref-NHM_pathways_6-1" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup><sup id="cite_ref-NHM_tuberoinfundibular_pathway_7-0" class="reference"><a href="#cite_note-NHM_tuberoinfundibular_pathway-7">&#91;7&#93;</a></sup> (same as above)
</p>
<dl><dd>Mesocorticolimbic
<ul><li><a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">VTA</a> → <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">Prefrontal cortex</a></li>
<li>VTA → <a href="/wiki/Ventral_striatum" class="mw-redirect" title="Ventral striatum">Ventral striatum</a> (<a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> and <a href="/wiki/Olfactory_tubercle" title="Olfactory tubercle">olfactory tubercle</a>)</li></ul></dd>
<dd>Nigrostriatal
<ul><li><a href="/wiki/Substantia_nigra_pars_compacta" class="mw-redirect" title="Substantia nigra pars compacta">SNc</a> → <a href="/wiki/Dorsal_striatum" class="mw-redirect" title="Dorsal striatum">Dorsal striatum</a> (<a href="/wiki/Caudate_nucleus" title="Caudate nucleus">caudate nucleus</a> and <a href="/wiki/Putamen" title="Putamen">putamen</a>)</li></ul></dd>
<dd>Tuberoinfundibular
<ul><li><a href="/wiki/Tuberal_region_of_hypothalamus" class="mw-redirect" title="Tuberal region of hypothalamus">Tuberal hypothalamus</a> (<a href="/wiki/Infundibular_nucleus" class="mw-redirect" title="Infundibular nucleus">Infundibular nucleus</a>) → <a href="/wiki/Median_eminence" title="Median eminence">Median eminence</a> (dopamine released at the median eminence reaches the <a href="/wiki/Pituitary_gland" title="Pituitary gland">pituitary gland</a> via the <a href="/wiki/Hypophyseal_portal_system" title="Hypophyseal portal system">hypophyseal portal system</a>)</li></ul></dd>
<dd>Hypothalamospinal
<ul><li><a href="/wiki/Hypothalamus" title="Hypothalamus">Hypothalamus</a> → <a href="/wiki/Spinal_cord" title="Spinal cord">Spinal cord</a></li></ul></dd>
<dd>Incertohypothalamic
<ul><li><a href="/wiki/Zona_incerta" title="Zona incerta">Zona incerta</a> → <a href="/wiki/Hypothalamus" title="Hypothalamus">Hypothalamus</a></li>
<li>Zona incerta → <a href="/wiki/Brainstem" title="Brainstem">Brainstem</a></li></ul></dd></dl>
<p><b>Other pathways</b>
</p>
<ul><li>VTA → <a href="/wiki/Amygdala" title="Amygdala">Amygdala</a> (mesoamygdaloid pathway)<sup id="cite_ref-NHM_pathways_6-2" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup></li>
<li>VTA → <a href="/wiki/Hippocampus" title="Hippocampus">Hippocampus</a><sup id="cite_ref-NHM_pathways_6-3" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup></li>
<li>VTA → <a href="/wiki/Cingulate_cortex" title="Cingulate cortex">Cingulate cortex</a><sup id="cite_ref-NHM_pathways_6-4" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup></li>
<li>VTA → <a href="/wiki/Olfactory_bulb" title="Olfactory bulb">Olfactory bulb</a><sup id="cite_ref-NHM_pathways_6-5" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup></li>
<li>SNc → <a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">Subthalamic nucleus</a><sup id="cite_ref-pmid15380000_8-0" class="reference"><a href="#cite_note-pmid15380000-8">&#91;8&#93;</a></sup></li></ul>
<h2><span class="mw-headline" id="Function">Function</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=2" title="Edit section: Function">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Mesocorticolimbic_projection">Mesocorticolimbic projection</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=3" title="Edit section: Mesocorticolimbic projection">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">mesocortical pathway</a> ( mesocorticolimbic system, mesocorticolimbic pathway) refers to both the <a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">mesocortical</a> and <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic</a> pathways.<sup id="cite_ref-projection_3-1" class="reference"><a href="#cite_note-projection-3">&#91;3&#93;</a></sup><sup id="cite_ref-MEDRS-quality_human_review_9-0" class="reference"><a href="#cite_note-MEDRS-quality_human_review-9">&#91;9&#93;</a></sup> Both pathways  originate at the ventral tegmental area (VTA). Through separate connections to the prefrontal cortex (mesocortical) and ventral striatum (mesolimbic), the mesocorticolimbic projection has a significant role in learning, motivation, reward, memory and movement.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup> Dopamine receptor subtypes, D1 and D2 have been shown to have complementary functions in the mesocorticolimbic projection, facilitating learning in response to both positive and negative feedback.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup> Both pathways of the mesocorticollimbic projection are associated with <a href="/wiki/ADHD" class="mw-redirect" title="ADHD">ADHD</a>, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a> and <a href="/wiki/Addiction" title="Addiction">addiction</a>.<sup id="cite_ref-NHM-Cognitive_Control_12-0" class="reference"><a href="#cite_note-NHM-Cognitive_Control-12">&#91;12&#93;</a></sup><sup id="cite_ref-ADHD_2008_paper_13-0" class="reference"><a href="#cite_note-ADHD_2008_paper-13">&#91;13&#93;</a></sup><sup id="cite_ref-:0_14-0" class="reference"><a href="#cite_note-:0-14">&#91;14&#93;</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> 
</p>
<h4><span class="mw-headline" id="Mesocortical_pathway">Mesocortical pathway</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=4" title="Edit section: Mesocortical pathway">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The <a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">mesocortical pathway</a> projects from the ventral tegmental area to the prefrontal cortex (<a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">VTA</a> → <a href="/wiki/Prefrontal_cortex" title="Prefrontal cortex">Prefrontal cortex</a>). This pathway is involved in cognition and the regulation of <a href="/wiki/Executive_function" class="mw-redirect" title="Executive function">executive functions</a> (e.g., attention, working memory, <a href="/wiki/Inhibitory_control" title="Inhibitory control">inhibitory control</a>, planning, etc.) Dysregulation of the neurons in this pathway has been connected to ADHD.<sup id="cite_ref-ADHD_2008_paper_13-1" class="reference"><a href="#cite_note-ADHD_2008_paper-13">&#91;13&#93;</a></sup>  
</p>
<h4><span class="mw-headline" id="Mesolimbic_pathway">Mesolimbic pathway</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=5" title="Edit section: Mesolimbic pathway">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Referred to as the reward pathway, <a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">mesolimbic pathway</a> projects from the ventral tegmental area to the ventral striatum ( VTA → <a href="/wiki/Ventral_striatum" class="mw-redirect" title="Ventral striatum">Ventral striatum</a> (<a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">nucleus accumbens</a> and <a href="/wiki/Olfactory_tubercle" title="Olfactory tubercle">olfactory tubercle</a>).<sup id="cite_ref-:0_14-1" class="reference"><a href="#cite_note-:0-14">&#91;14&#93;</a></sup> When a reward is anticipated, the firing rate of dopamine neurons in the mesolimbic pathway increases.<sup id="cite_ref-:1_16-0" class="reference"><a href="#cite_note-:1-16">&#91;16&#93;</a></sup> The mesolimbic pathway is involved with <a href="/wiki/Incentive_salience" class="mw-redirect" title="Incentive salience">incentive salience</a>, <a href="/wiki/Motivation" title="Motivation">motivation</a>, reinforcement learning, fear and other cognitive processes.<sup id="cite_ref-NHM_pathways_6-6" class="reference"><a href="#cite_note-NHM_pathways-6">&#91;6&#93;</a></sup><sup id="cite_ref-ADHD_2008_paper_13-2" class="reference"><a href="#cite_note-ADHD_2008_paper-13">&#91;13&#93;</a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup> In animal studies, depletion of dopamine in this pathway, or lesions at its site of origin, decrease the extent to which an animal is willing to go to obtain a reward (e.g., the number of lever presses for nicotine or time searching for food).<sup id="cite_ref-:1_16-1" class="reference"><a href="#cite_note-:1-16">&#91;16&#93;</a></sup> Research is ongoing to determine the role of the mesolimbic pathway in the perception of pleasure.<sup id="cite_ref-Pleasure_system_18-0" class="reference"><a href="#cite_note-Pleasure_system-18">&#91;18&#93;</a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Cortico-basal_ganglia-thalamo-cortical_loop">Cortico-basal ganglia-thalamo-cortical loop</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=6" title="Edit section: Cortico-basal ganglia-thalamo-cortical loop">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The dopaminergic pathways that project from the <a href="/wiki/Substantia_nigra_pars_compacta" class="mw-redirect" title="Substantia nigra pars compacta">substantia nigra pars compacta</a> (SNc) and <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">ventral tegmental area</a> (VTA) into the <a href="/wiki/Striatum" title="Striatum">striatum</a> (i.e., the nigrostriatal and mesolimbic pathways, respectively) form one component of a sequence of pathways known as the <a href="/wiki/Cortico-basal_ganglia-thalamo-cortical_loop" title="Cortico-basal ganglia-thalamo-cortical loop">cortico-basal ganglia-thalamo-cortical loop</a>.<sup id="cite_ref-Reward_system_components_and_structure-specific_functions_22-0" class="reference"><a href="#cite_note-Reward_system_components_and_structure-specific_functions-22">&#91;22&#93;</a></sup><sup id="cite_ref-Striatal_efferents,_afferents,_and_colocalized_receptors_in_dMSNs_and_iMSNs_23-0" class="reference"><a href="#cite_note-Striatal_efferents,_afferents,_and_colocalized_receptors_in_dMSNs_and_iMSNs-23">&#91;23&#93;</a></sup> The nigrostriatal component of the loop consists of the SNc, giving rise to both inhibitory and excitatory pathways that run from the striatum into the <a href="/wiki/Globus_pallidus" title="Globus pallidus">globus pallidus</a>, before carrying on to the thalamus, or into the <a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">subthalamic nucleus</a> before heading into the <a href="/wiki/Thalamus" title="Thalamus">thalamus</a>. The dopaminergic neurons in this circuit increase the magnitude of phasic firing in response to positive reward error, that is when the reward exceeds the expected reward.  These neurons do not decrease phasic firing during a negative reward prediction (less reward than expected), leading to hypothesis that serotonergic, rather than dopaminergic neurons encode reward loss (source?). Dopamine phasic activity also increases during cues that signal negative events, however dopaminergic neuron stimulation still induces place preference, indicating its main role in evaluating a positive stimulus.  From these findings, two hypotheses have developed, as to the role of the basal ganglia and nigrostiatal dopamine circuits in action selection.  The first model suggests a "critic" which encodes value, and an actor which encodes responses to stimuli based on perceived value.  However, the second model proposes that the actions do not originate in the basal ganglia, and instead originate in the cortex and are selected by the basal ganglia.  This model proposes that the direct pathway controls appropriate behavior and the indirect suppresses actions not suitable for the situation.  This model proposes that tonic dopaminergic firing increases the activity of the direct pathway, causing a bias towards executing actions faster.<sup id="cite_ref-pmid21270784_24-0" class="reference"><a href="#cite_note-pmid21270784-24">&#91;24&#93;</a></sup>
</p><p>These models of the basal ganglia are thought to be relevant to the study of <a href="/wiki/ADHD" class="mw-redirect" title="ADHD">ADHD</a>, <a href="/wiki/Tourette_syndrome" title="Tourette syndrome">Tourette syndrome</a>, <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a>, <a href="/wiki/Schizophrenia" title="Schizophrenia">schizophrenia</a>, <a href="/wiki/OCD" class="mw-redirect" title="OCD">OCD</a>,<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup><sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup> and <a href="/wiki/Addiction" title="Addiction">addiction</a>.  For example, <a href="/wiki/Parkinson%27s_disease" title="Parkinson&#39;s disease">Parkinson's disease</a> is hypothesized to be a result of excessive inhibitory pathway activity, which explains the slow movement and cognitive deficits, while Tourettes is proposed to be a result of excessive excitatory activity resulting in the tics characteristic of Tourettes.<sup id="cite_ref-pmid21270784_24-1" class="reference"><a href="#cite_note-pmid21270784-24">&#91;24&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Regulation">Regulation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=7" title="Edit section: Regulation">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">ventral tegmental area</a> and <a href="/wiki/Substantia_nigra_pars_compacta" class="mw-redirect" title="Substantia nigra pars compacta">substantia nigra pars compacta</a> receive inputs from other neurotransmitters systems, including <a href="/wiki/Glutamate_(neurotransmitter)" title="Glutamate (neurotransmitter)">glutaminergic</a> inputs, <a href="/wiki/GABA" class="mw-redirect" title="GABA">GABAergic</a> inputs, cholinergic inputs, and inputs from other monoaminergic nuclei. The VTA contains <a href="/wiki/5-HT1A" class="mw-redirect" title="5-HT1A">5-HT<sub>1A</sub> receptors</a> that exert a biphasic effects on <a href="/wiki/Action_potential" title="Action potential">firing</a>, with low doses of 5-HT<sub>1A</sub> receptor agonists eliciting an increase in firing rate, and higher doses suppressing activity.  The <a href="/wiki/5-HT2A" class="mw-redirect" title="5-HT2A">5-HT<sub>2A</sub> receptors</a> expressed on dopaminergic neurons increase activity, while <a href="/wiki/5-HT2C" class="mw-redirect" title="5-HT2C">5-HT<sub>2C</sub> receptors</a> elicit a decrease in activity.<sup id="cite_ref-5-ht_da_27-0" class="reference"><a href="#cite_note-5-ht_da-27">&#91;27&#93;</a></sup>  The mesolimbic pathway, which projects from the VTA to the nucleus accumbens, is also regulated by <a href="/wiki/Muscarinic_acetylcholine_receptor" title="Muscarinic acetylcholine receptor">muscarinic acetylcholine receptors</a>.  In particular, the activation of <a href="/wiki/Muscarinic_acetylcholine_receptor_M2" title="Muscarinic acetylcholine receptor M2">muscarinic acetylcholine receptor M2</a> and <a href="/wiki/Muscarinic_acetylcholine_receptor_M4" title="Muscarinic acetylcholine receptor M4">muscarinic acetylcholine receptor M4</a> inhibits dopamine release, while <a href="/wiki/Muscarinic_acetylcholine_receptor_M1" title="Muscarinic acetylcholine receptor M1">muscarinic acetylcholine receptor M1</a> activation increases dopamine release.<sup id="cite_ref-cholinergic_28-0" class="reference"><a href="#cite_note-cholinergic-28">&#91;28&#93;</a></sup>  GABAergic inputs from the striatum decrease dopaminergic neuronal activity, and glutaminergic inputs from many cortical and subcortical areas increase the firing rate of dopaminergic neurons.  Endocannabinoids also appear to have a modulatory effect on dopamine release from neurons that project out of the VTA and SNc.<sup id="cite_ref-endocannabinoid_inhibition_29-0" class="reference"><a href="#cite_note-endocannabinoid_inhibition-29">&#91;29&#93;</a></sup>  <a href="/wiki/Norepinephrine" title="Norepinephrine">Noradrenergic</a> inputs deriving from the <a href="/wiki/Locus_coeruleus" title="Locus coeruleus">locus coeruleus</a> have excitatory and inhibitory effects on the dopaminergic neurons that project out of the VTA and SNc.<sup id="cite_ref-da_regulation_30-0" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup><sup id="cite_ref-Noradrenergic_modulation_of_DA_neurons_-_2014_review_31-0" class="reference"><a href="#cite_note-Noradrenergic_modulation_of_DA_neurons_-_2014_review-31">&#91;31&#93;</a></sup> The excitatory <a href="/wiki/Orexin" title="Orexin">orexinergic</a> inputs to the VTA originate in the <a href="/wiki/Lateral_hypothalamus" title="Lateral hypothalamus">lateral hypothalamus</a> and may regulate the baseline <a href="/wiki/Action_potential" title="Action potential">firing</a> of VTA dopaminergic neurons.<sup id="cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-0" class="reference"><a href="#cite_note-Cannabinoid-Orexin_systemic_cross-talk-32">&#91;32&#93;</a></sup><sup id="cite_ref-pmid19815001_33-0" class="reference"><a href="#cite_note-pmid19815001-33">&#91;33&#93;</a></sup>
</p>
<table class="wikitable">
<caption>Inputs to the ventral tegmental area (VTA) and substantia nigra pars compacta (SNc)
</caption>
<tbody><tr>
<th scope="col"><a href="/wiki/Neurotransmitter" title="Neurotransmitter">Neurotransmitter</a>
</th>
<th scope="col">Origin
</th>
<th scope="col">Type of Connection
</th>
<th scope="col"><small>Sources</small>
</th></tr>
<tr>
<th scope="row"><a href="/wiki/Glutamate_(neurotransmitter)" title="Glutamate (neurotransmitter)">Glutamate</a>
</th>
<td>
<ul><li><a href="/wiki/Pedunculopontine_nucleus" title="Pedunculopontine nucleus">pedunculopontine nucleus</a></li>
<li><a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">subthalamic nucleus</a></li>
<li><a href="/wiki/Laterodorsal_tegmental_nucleus" title="Laterodorsal tegmental nucleus">laterodorsal tegmental nucleus</a></li>
<li><a href="/wiki/Stria_terminalis" title="Stria terminalis">stria terminalis</a></li>
<li><a href="/wiki/Superior_colliculus" title="Superior colliculus">superior colliculus</a></li>
<li><a href="/wiki/Lateral_hypothalamus" title="Lateral hypothalamus">lateral hypothalamus</a></li>
<li><a href="/wiki/Preoptic_area" title="Preoptic area">preoptic area</a></li>
<li><a href="/wiki/Periaqueductal_gray" title="Periaqueductal gray">periaqueductal gray</a></li>
<li><a href="/wiki/Raphe_nuclei" title="Raphe nuclei">raphe nuclei</a></li></ul>
</td>
<td>Excitatory projections into the VTA and SNc
</td>
<td><sup id="cite_ref-da_regulation_30-1" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup>
</td></tr>
<tr>
<th scope="row"><a href="/wiki/GABA" class="mw-redirect" title="GABA">GABA</a>
</th>
<td>
<ul><li><a href="/wiki/Rostromedial_tegmental_nucleus" title="Rostromedial tegmental nucleus">rostromedial tegmental nucleus</a></li>
<li><a href="/wiki/Striatum" title="Striatum">striatum</a></li>
<li>local GABAergic inputs</li></ul>
</td>
<td>Inhibitory projections into the VTA and SNc
</td>
<td><sup id="cite_ref-da_regulation_30-2" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup>
</td></tr>
<tr>
<th scope="row"><a href="/wiki/Serotonin" title="Serotonin">Serotonin</a>
</th>
<td>
<ul><li><a href="/wiki/Raphe_nuclei" title="Raphe nuclei">raphe nuclei</a></li></ul>
</td>
<td>Modulatory effect, depending on receptor subtype<br />Produces a biphasic effect on VTA neurons
</td>
<td><sup id="cite_ref-da_regulation_30-3" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup>
</td></tr>
<tr>
<th scope="row"><a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine</a>
</th>
<td>
<ul><li><a href="/wiki/Locus_coeruleus" title="Locus coeruleus">locus coeruleus</a></li>
<li>other noradrenergic nuclei</li></ul>
</td>
<td>Modulatory effect, depending on receptor subtype<br />The excitatory and inhibitory effects of the <abbr title="locus coeruleus">LC</abbr> on the VTA and SNc are time-dependent
</td>
<td><sup id="cite_ref-da_regulation_30-4" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup><sup id="cite_ref-Noradrenergic_modulation_of_DA_neurons_-_2014_review_31-1" class="reference"><a href="#cite_note-Noradrenergic_modulation_of_DA_neurons_-_2014_review-31">&#91;31&#93;</a></sup>
</td></tr>
<tr>
<th scope="row"><a href="/wiki/Endocannabinoid" class="mw-redirect" title="Endocannabinoid">Endocannabinoids</a>
</th>
<td>
<ul><li>VTA dopamine neurons<sup id="cite_ref-retrograde_neurotransmission_34-0" class="reference"><a href="#cite_note-retrograde_neurotransmission-34">&#91;note 1&#93;</a></sup></li>
<li>SNc dopamine neurons<sup id="cite_ref-retrograde_neurotransmission_34-1" class="reference"><a href="#cite_note-retrograde_neurotransmission-34">&#91;note 1&#93;</a></sup></li></ul>
</td>
<td>Excitatory effect on dopaminergic neurons from inhibiting GABAergic inputs<br /> Inhibitory effect on dopaminergic neurons from inhibiting glutamatergic inputs<br /> May interact with orexins via <a href="/wiki/Cannabinoid_receptor_1" class="mw-redirect" title="Cannabinoid receptor 1">CB1</a>–<a href="/wiki/Orexin_receptor" title="Orexin receptor">OX1</a> <a href="/wiki/GPCR_oligomer" title="GPCR oligomer">receptor heterodimers</a> to regulate neuronal firing
</td>
<td><sup id="cite_ref-endocannabinoid_inhibition_29-2" class="reference"><a href="#cite_note-endocannabinoid_inhibition-29">&#91;29&#93;</a></sup><sup id="cite_ref-da_regulation_30-5" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup><sup id="cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-4" class="reference"><a href="#cite_note-Cannabinoid-Orexin_systemic_cross-talk-32">&#91;32&#93;</a></sup><sup id="cite_ref-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1_35-0" class="reference"><a href="#cite_note-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1-35">&#91;34&#93;</a></sup>
</td></tr>
<tr>
<th scope="row"><a href="/wiki/Acetylcholine" title="Acetylcholine">Acetylcholine</a>
</th>
<td>
<ul><li><a href="/wiki/Pedunculopontine_nucleus" title="Pedunculopontine nucleus">pedunculopontine nucleus</a></li>
<li><a href="/wiki/Laterodorsal_tegmental_nuclei" class="mw-redirect" title="Laterodorsal tegmental nuclei">laterodorsal tegmental nuclei</a></li></ul>
</td>
<td>Modulatory effect, depending on receptor subtype
</td>
<td><sup id="cite_ref-da_regulation_30-6" class="reference"><a href="#cite_note-da_regulation-30">&#91;30&#93;</a></sup>
</td></tr>
<tr>
<th scope="row"><a href="/wiki/Orexin" title="Orexin">Orexin</a>
</th>
<td>
<ul><li><a href="/wiki/Lateral_hypothalamus" title="Lateral hypothalamus">lateral hypothalamus</a></li></ul>
</td>
<td>Excitatory effect on dopaminergic neurons via signaling through <a href="/wiki/Orexin_receptor" title="Orexin receptor">orexin receptors</a> (<a href="/wiki/Orexin_receptor_1" class="mw-redirect" title="Orexin receptor 1">OX1</a> and <a href="/wiki/Orexin_receptor_2" class="mw-redirect" title="Orexin receptor 2">OX2</a>)<br />Increases both tonic and phasic firing of dopaminergic neurons in the VTA<br />May interact with endocannabinoids via <a href="/wiki/Cannabinoid_receptor_1" class="mw-redirect" title="Cannabinoid receptor 1">CB1</a>–<a href="/wiki/Orexin_receptor" title="Orexin receptor">OX1</a> <a href="/wiki/GPCR_oligomer" title="GPCR oligomer">receptor heterodimers</a> to regulate neuronal firing
</td>
<td><sup id="cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-5" class="reference"><a href="#cite_note-Cannabinoid-Orexin_systemic_cross-talk-32">&#91;32&#93;</a></sup><sup id="cite_ref-pmid19815001_33-1" class="reference"><a href="#cite_note-pmid19815001-33">&#91;33&#93;</a></sup><sup id="cite_ref-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1_35-1" class="reference"><a href="#cite_note-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1-35">&#91;34&#93;</a></sup>
</td></tr></tbody></table>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=8" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Dopaminergic_cell_groups" title="Dopaminergic cell groups">Dopaminergic cell groups</a></li></ul>
<h2><span class="mw-headline" id="Notes">Notes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=9" title="Edit section: Notes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap"><ol class="references">
<li id="cite_note-retrograde_neurotransmission-34"><span class="mw-cite-backlink">^ <a href="#cite_ref-retrograde_neurotransmission_34-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-retrograde_neurotransmission_34-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">At a <a href="/wiki/Chemical_synapse#Structure" title="Chemical synapse">chemical synapse</a>, neurotransmitters are normally released from the presynaptic <a href="/wiki/Axon_terminal" title="Axon terminal">axon terminal</a> and signal through receptors that are located on the <a href="/wiki/Dendrite" title="Dendrite">dendrites</a> of the postsynaptic neuron; however, in <a href="/wiki/Retrograde_neurotransmission" class="mw-redirect" title="Retrograde neurotransmission">retrograde neurotransmission</a>, the dendrites of the postsynaptic neuron release neurotransmitters that signal through receptors that are located on the axon terminal of the presynaptic neuron.<sup id="cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-1" class="reference"><a href="#cite_note-Cannabinoid-Orexin_systemic_cross-talk-32">&#91;32&#93;</a></sup><br />Endocannabinoids signal between neurons through retrograde neurotransmission at synapses;<sup id="cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-2" class="reference"><a href="#cite_note-Cannabinoid-Orexin_systemic_cross-talk-32">&#91;32&#93;</a></sup> consequently, the dopaminergic neurons that project out of the VTA and SNc release endocannabinoids from their dendrites onto the axon terminals of their inhibitory GABAergic and excitatory glutamatergic inputs to inhibit their effects on dopamine neuronal firing.<sup id="cite_ref-endocannabinoid_inhibition_29-1" class="reference"><a href="#cite_note-endocannabinoid_inhibition-29">&#91;29&#93;</a></sup><sup id="cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-3" class="reference"><a href="#cite_note-Cannabinoid-Orexin_systemic_cross-talk-32">&#91;32&#93;</a></sup></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Dopaminergic_pathways&amp;action=edit&amp;section=10" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1011085734"/><div class="reflist reflist-columns references-column-width reflist-columns-2" style="">
<ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-1">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFAlcaroHuberPanksepp2007" class="citation journal cs1">Alcaro A, Huber R, Panksepp J (December 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2238694">"Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective"</a>. <i>Brain Research Reviews</i>. <b>56</b> (2): 283–321. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.brainresrev.2007.07.014">10.1016/j.brainresrev.2007.07.014</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2238694">2238694</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17905440">17905440</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Research+Reviews&amp;rft.atitle=Behavioral+functions+of+the+mesolimbic+dopaminergic+system%3A+an+affective+neuroethological+perspective&amp;rft.volume=56&amp;rft.issue=2&amp;rft.pages=283-321&amp;rft.date=2007-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2238694%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17905440&amp;rft_id=info%3Adoi%2F10.1016%2Fj.brainresrev.2007.07.014&amp;rft.aulast=Alcaro&amp;rft.aufirst=A&amp;rft.au=Huber%2C+R&amp;rft.au=Panksepp%2C+J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2238694&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-urlBeyond_the_Reward_Pathway-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlBeyond_the_Reward_Pathway_2-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20100209020641/http://learn.genetics.utah.edu/content/addiction/reward/pathways.html">"Beyond the Reward Pathway"</a>. <i>Learn Genetics</i>. University of Utah. Archived from <a rel="nofollow" class="external text" href="http://learn.genetics.utah.edu/content/addiction/reward/pathways.html">the original</a> on 2010-02-09<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-10-23</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Learn+Genetics&amp;rft.atitle=Beyond+the+Reward+Pathway&amp;rft_id=http%3A%2F%2Flearn.genetics.utah.edu%2Fcontent%2Faddiction%2Freward%2Fpathways.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-projection-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-projection_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-projection_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLe_Moal1995" class="citation book cs1">Le Moal M (1995). "Mesocorticolimbic Dopaminergic Neurons: Functional and Regulatory Roles".  In Bloom FE, Kupfer DJ (eds.). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20180205211300/http://www.acnp.org/g4/gn401000025/ch025.html"><i>Psychopharmacology: the fourth generation of progress</i></a>. New York: Raven Press. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-0166-2" title="Special:BookSources/978-0-7817-0166-2"><bdi>978-0-7817-0166-2</bdi></a>. Archived from <a rel="nofollow" class="external text" href="http://www.acnp.org/g4/gn401000025/ch025.html">the original</a> on 5 February 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Mesocorticolimbic+Dopaminergic+Neurons%3A+Functional+and+Regulatory+Roles&amp;rft.btitle=Psychopharmacology%3A+the+fourth+generation+of+progress&amp;rft.place=New+York&amp;rft.pub=Raven+Press&amp;rft.date=1995&amp;rft.isbn=978-0-7817-0166-2&amp;rft.aulast=Le+Moal&amp;rft.aufirst=M&amp;rft_id=http%3A%2F%2Fwww.acnp.org%2Fg4%2Fgn401000025%2Fch025.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Harsing_2000-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Harsing_2000_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Harsing_2000_4-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHarsing2008" class="citation book cs1">Harsing LG (2008). "Dopamine and the Dopaminergic Systems of the Brain".  In Lajtha A, Vizi ES (eds.). <i>Handbook of Neurochemistry and Molecular Neurobiology</i>. Boston, MA: Springer US. pp.&#160;149–170. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-0-387-30382-6_7">10.1007/978-0-387-30382-6_7</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-387-30351-2" title="Special:BookSources/978-0-387-30351-2"><bdi>978-0-387-30351-2</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Dopamine+and+the+Dopaminergic+Systems+of+the+Brain&amp;rft.btitle=Handbook+of+Neurochemistry+and+Molecular+Neurobiology&amp;rft.place=Boston%2C+MA&amp;rft.pages=149-170&amp;rft.pub=Springer+US&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1007%2F978-0-387-30382-6_7&amp;rft.isbn=978-0-387-30351-2&amp;rft.aulast=Harsing&amp;rft.aufirst=LG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Dopaminergic_pathways_and_reward_system_review-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-Dopaminergic_pathways_and_reward_system_review_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dopaminergic_pathways_and_reward_system_review_5-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFIkemoto2010" class="citation journal cs1">Ikemoto S (November 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2894302">"Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory"</a>. <i>Neuroscience and Biobehavioral Reviews</i>. <b>35</b> (2): 129–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neubiorev.2010.02.001">10.1016/j.neubiorev.2010.02.001</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2894302">2894302</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20149820">20149820</a>. <q>Recent studies on intracranial self-administration of neurochemicals (drugs) found that rats learn to self-administer various drugs into the mesolimbic dopamine structures–the posterior ventral tegmental area, medial shell nucleus accumbens and medial olfactory tubercle.&#160;... In the 1970s it was recognized that the olfactory tubercle contains a striatal component, which is filled with GABAergic medium spiny neurons receiving glutamatergic inputs form cortical regions and dopaminergic inputs from the VTA and projecting to the ventral pallidum just like the nucleus accumbens</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroscience+and+Biobehavioral+Reviews&amp;rft.atitle=Brain+reward+circuitry+beyond+the+mesolimbic+dopamine+system%3A+a+neurobiological+theory&amp;rft.volume=35&amp;rft.issue=2&amp;rft.pages=129-50&amp;rft.date=2010-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2894302%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20149820&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neubiorev.2010.02.001&amp;rft.aulast=Ikemoto&amp;rft.aufirst=S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2894302&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span><br /><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894302/figure/F3/">Figure 3: The ventral striatum and self-administration of amphetamine</a></span>
</li>
<li id="cite_note-NHM_pathways-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-NHM_pathways_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NHM_pathways_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NHM_pathways_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NHM_pathways_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NHM_pathways_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NHM_pathways_6-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NHM_pathways_6-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMalenkaNestlerHyman2009" class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 6: Widely Projecting Systems: Monoamines, Acetylcholine, and Orexin".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd&#160;ed.). New York: McGraw-Hill Medical. pp.&#160;147–148, 154–157. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780071481274" title="Special:BookSources/9780071481274"><bdi>9780071481274</bdi></a>. <q>Neurons from the SNc densely innervate the dorsal striatum where they play a critical role in the learning and execution of motor programs.  Neurons from the VTA innervate the ventral striatum (nucleus accumbens), olfactory bulb, amygdala, hippocampus, orbital and medial prefrontal cortex, and cingulate cortex. VTA DA neurons play a critical role in motivation, reward-related behavior, attention, and multiple forms of memory.&#160;... Thus, acting in diverse terminal fields, dopamine confers motivational salience ("wanting") on the reward itself or associated cues (nucleus accumbens shell region), updates the value placed on different goals in light of this new experience (orbital prefrontal cortex), helps consolidate multiple forms of memory (amygdala and hippocampus), and encodes new motor programs that will facilitate obtaining this reward in the future (nucleus accumbens core region and dorsal striatum).&#160;... DA has multiple actions in the prefrontal cortex.  It promotes the "cognitive control" of behavior: the selection and successful monitoring of behavior to facilitate attainment of chosen goals.  Aspects of cognitive control in which DA plays a role include working memory, the ability to hold information "on line" in order to guide actions, suppression of prepotent behaviors that compete with goal-directed actions, and control of attention and thus the ability to overcome distractions.&#160;... Noradrenergic projections from the LC thus interact with dopaminergic projections from the VTA to regulate cognitive control.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+6%3A+Widely+Projecting+Systems%3A+Monoamines%2C+Acetylcholine%2C+and+Orexin&amp;rft.btitle=Molecular+Neuropharmacology%3A+A+Foundation+for+Clinical+Neuroscience&amp;rft.place=New+York&amp;rft.pages=147-148%2C+154-157&amp;rft.edition=2nd&amp;rft.pub=McGraw-Hill+Medical&amp;rft.date=2009&amp;rft.isbn=9780071481274&amp;rft.aulast=Malenka&amp;rft.aufirst=RC&amp;rft.au=Nestler%2C+EJ&amp;rft.au=Hyman%2C+SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-NHM_tuberoinfundibular_pathway-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-NHM_tuberoinfundibular_pathway_7-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMalenkaNestlerHyman2009" class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 10: Neural and Neuroendocrine Control of the Internal Milieu".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd&#160;ed.). New York: McGraw-Hill Medical. p.&#160;249. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780071481274" title="Special:BookSources/9780071481274"><bdi>9780071481274</bdi></a>. <q>Relationship of the hypothalamus and the pituitary gland. The anterior pituitary, or adenohypophysis, receives rich blood flow from the capillaries of the portal hypophyseal system. This system delivers factors released by hypothalamic neurons into portal capillaries at the median eminence. The figure shows one such projection, from the tuberal (arcuate) nuclei via the tuberoinfundibular tract to the median eminence.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+10%3A+Neural+and+Neuroendocrine+Control+of+the+Internal+Milieu&amp;rft.btitle=Molecular+Neuropharmacology%3A+A+Foundation+for+Clinical+Neuroscience&amp;rft.place=New+York&amp;rft.pages=249&amp;rft.edition=2nd&amp;rft.pub=McGraw-Hill+Medical&amp;rft.date=2009&amp;rft.isbn=9780071481274&amp;rft.aulast=Malenka&amp;rft.aufirst=RC&amp;rft.au=Nestler%2C+EJ&amp;rft.au=Hyman%2C+SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15380000-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15380000_8-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCraggBaufretonXueBolam2004" class="citation journal cs1">Cragg SJ, Baufreton J, Xue Y, Bolam JP, Bevan MD (October 2004). "Synaptic release of dopamine in the subthalamic nucleus". <i>The European Journal of Neuroscience</i>. <b>20</b> (7): 1788–802. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1460-9568.2004.03629.x">10.1111/j.1460-9568.2004.03629.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15380000">15380000</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:14698708">14698708</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+European+Journal+of+Neuroscience&amp;rft.atitle=Synaptic+release+of+dopamine+in+the+subthalamic+nucleus&amp;rft.volume=20&amp;rft.issue=7&amp;rft.pages=1788-802&amp;rft.date=2004-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A14698708%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15380000&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1460-9568.2004.03629.x&amp;rft.aulast=Cragg&amp;rft.aufirst=SJ&amp;rft.au=Baufreton%2C+J&amp;rft.au=Xue%2C+Y&amp;rft.au=Bolam%2C+JP&amp;rft.au=Bevan%2C+MD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-MEDRS-quality_human_review-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-MEDRS-quality_human_review_9-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDoyonThomasOstroumovDong2013" class="citation journal cs1">Doyon WM, Thomas AM, Ostroumov A, Dong Y, Dani JA (October 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3800178">"Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system"</a>. <i>Biochemical Pharmacology</i>. <b>86</b> (8): 1181–93. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bcp.2013.07.007">10.1016/j.bcp.2013.07.007</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3800178">3800178</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23876345">23876345</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+Pharmacology&amp;rft.atitle=Potential+substrates+for+nicotine+and+alcohol+interactions%3A+a+focus+on+the+mesocorticolimbic+dopamine+system&amp;rft.volume=86&amp;rft.issue=8&amp;rft.pages=1181-93&amp;rft.date=2013-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3800178%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23876345&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bcp.2013.07.007&amp;rft.aulast=Doyon&amp;rft.aufirst=WM&amp;rft.au=Thomas%2C+AM&amp;rft.au=Ostroumov%2C+A&amp;rft.au=Dong%2C+Y&amp;rft.au=Dani%2C+JA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3800178&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFYamaguchiWangLiNg2011" class="citation journal cs1">Yamaguchi T, Wang HL, Li X, Ng TH, Morales M (June 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6623324">"Mesocorticolimbic glutamatergic pathway"</a>. <i>The Journal of Neuroscience</i>. <b>31</b> (23): 8476–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1523%2FJNEUROSCI.1598-11.2011">10.1523/JNEUROSCI.1598-11.2011</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6623324">6623324</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21653852">21653852</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Journal+of+Neuroscience&amp;rft.atitle=Mesocorticolimbic+glutamatergic+pathway&amp;rft.volume=31&amp;rft.issue=23&amp;rft.pages=8476-90&amp;rft.date=2011-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6623324%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21653852&amp;rft_id=info%3Adoi%2F10.1523%2FJNEUROSCI.1598-11.2011&amp;rft.aulast=Yamaguchi&amp;rft.aufirst=T&amp;rft.au=Wang%2C+HL&amp;rft.au=Li%2C+X&amp;rft.au=Ng%2C+TH&amp;rft.au=Morales%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6623324&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVerharenAdanVanderschuren2019" class="citation journal cs1">Verharen JP, Adan RA, Vanderschuren LJ (December 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6897916">"Differential contributions of striatal dopamine D1 and D2 receptors to component processes of value-based decision making"</a>. <i>Neuropsychopharmacology</i>. <b>44</b> (13): 2195–2204. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41386-019-0454-0">10.1038/s41386-019-0454-0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6897916">6897916</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31254972">31254972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychopharmacology&amp;rft.atitle=Differential+contributions+of+striatal+dopamine+D1+and+D2+receptors+to+component+processes+of+value-based+decision+making&amp;rft.volume=44&amp;rft.issue=13&amp;rft.pages=2195-2204&amp;rft.date=2019-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6897916%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31254972&amp;rft_id=info%3Adoi%2F10.1038%2Fs41386-019-0454-0&amp;rft.aulast=Verharen&amp;rft.aufirst=JP&amp;rft.au=Adan%2C+RA&amp;rft.au=Vanderschuren%2C+LJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6897916&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-NHM-Cognitive_Control-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-NHM-Cognitive_Control_12-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMalenkaNestlerHyman2009" class="citation book cs1">Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 13: Higher Cognitive Function and Behavioral Control".  In Sydor A, Brown RY (eds.). <i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience</i> (2nd&#160;ed.). New York: McGraw-Hill Medical. pp.&#160;313–321. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780071481274" title="Special:BookSources/9780071481274"><bdi>9780071481274</bdi></a>. <q>&#160;&#8226;&#32; Executive function, the cognitive control of behavior, depends on the prefrontal cortex, which is highly developed in higher primates and especially humans.<br />&#160;&#8226;&#32; Working memory is a short-term, capacity-limited cognitive buffer that stores information and permits its manipulation to guide decision-making and behavior.&#160;...<br /> These diverse inputs and back projections to both cortical and subcortical structures put the prefrontal cortex in a position to exert what is often called “top-down” control or cognitive control of behavior.&#160;... The prefrontal cortex receives inputs not only from other cortical regions, including association cortex, but also, via the thalamus, inputs from subcortical structures subserving emotion and motivation, such as the amygdala (Chapter 14) and ventral striatum (or nucleus accumbens; Chapter 15).&#160;...<br />In conditions in which prepotent responses tend to dominate behavior, such as in drug addiction, where drug cues can elicit drug seeking (Chapter 15), or in attention deficit hyperactivity disorder (ADHD; described below), significant negative consequences can result.&#160;... ADHD can be conceptualized as a disorder of executive function; specifically, ADHD is characterized by reduced ability to exert and maintain cognitive control of behavior. Compared with healthy individuals, those with ADHD have diminished ability to suppress inappropriate prepotent responses to stimuli (impaired response inhibition) and diminished ability to inhibit responses to irrelevant stimuli (impaired interference suppression).&#160;... Functional neuroimaging in humans demonstrates activation of the prefrontal cortex and caudate nucleus (part of the striatum) in tasks that demand inhibitory control of behavior.&#160;... Early results with structural MRI show thinning of the cerebral cortex in ADHD subjects compared with age-matched controls in prefrontal cortex and posterior parietal cortex, areas involved in working memory and attention.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+13%3A+Higher+Cognitive+Function+and+Behavioral+Control&amp;rft.btitle=Molecular+Neuropharmacology%3A+A+Foundation+for+Clinical+Neuroscience&amp;rft.place=New+York&amp;rft.pages=313-321&amp;rft.edition=2nd&amp;rft.pub=McGraw-Hill+Medical&amp;rft.date=2009&amp;rft.isbn=9780071481274&amp;rft.aulast=Malenka&amp;rft.aufirst=RC&amp;rft.au=Nestler%2C+EJ&amp;rft.au=Hyman%2C+SE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-ADHD_2008_paper-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-ADHD_2008_paper_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ADHD_2008_paper_13-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ADHD_2008_paper_13-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFEngertPruessner2008" class="citation journal cs1">Engert V, Pruessner JC (December 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2701285">"Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate"</a>. <i>Current Neuropharmacology</i>. <b>6</b> (4): 322–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F157015908787386069">10.2174/157015908787386069</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2701285">2701285</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19587853">19587853</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neuropharmacology&amp;rft.atitle=Dopaminergic+and+noradrenergic+contributions+to+functionality+in+ADHD%3A+the+role+of+methylphenidate&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=322-8&amp;rft.date=2008-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2701285%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19587853&amp;rft_id=info%3Adoi%2F10.2174%2F157015908787386069&amp;rft.aulast=Engert&amp;rft.aufirst=V&amp;rft.au=Pruessner%2C+JC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2701285&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-:0-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDreyer2010" class="citation journal cs1">Dreyer JL (December 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3025434">"New insights into the roles of microRNAs in drug addiction and neuroplasticity"</a>. <i>Genome Medicine</i>. <b>2</b> (12): 92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fgm213">10.1186/gm213</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3025434">3025434</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21205279">21205279</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genome+Medicine&amp;rft.atitle=New+insights+into+the+roles+of+microRNAs+in+drug+addiction+and+neuroplasticity&amp;rft.volume=2&amp;rft.issue=12&amp;rft.pages=92&amp;rft.date=2010-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3025434%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21205279&amp;rft_id=info%3Adoi%2F10.1186%2Fgm213&amp;rft.aulast=Dreyer&amp;rft.aufirst=JL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3025434&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRobisonNestler2011" class="citation journal cs1">Robison AJ, Nestler EJ (October 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277">"Transcriptional and epigenetic mechanisms of addiction"</a>. <i>Nature Reviews. Neuroscience</i>. <b>12</b> (11): 623–37. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrn3111">10.1038/nrn3111</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3272277">3272277</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21989194">21989194</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neuroscience&amp;rft.atitle=Transcriptional+and+epigenetic+mechanisms+of+addiction&amp;rft.volume=12&amp;rft.issue=11&amp;rft.pages=623-37&amp;rft.date=2011-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3272277%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21989194&amp;rft_id=info%3Adoi%2F10.1038%2Fnrn3111&amp;rft.aulast=Robison&amp;rft.aufirst=AJ&amp;rft.au=Nestler%2C+EJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3272277&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-:1-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSalamoneCorrea2012" class="citation journal cs1">Salamone JD, Correa M (November 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4450094">"The mysterious motivational functions of mesolimbic dopamine"</a>. <i>Neuron</i>. <b>76</b> (3): 470–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuron.2012.10.021">10.1016/j.neuron.2012.10.021</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4450094">4450094</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23141060">23141060</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuron&amp;rft.atitle=The+mysterious+motivational+functions+of+mesolimbic+dopamine&amp;rft.volume=76&amp;rft.issue=3&amp;rft.pages=470-85&amp;rft.date=2012-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4450094%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23141060&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuron.2012.10.021&amp;rft.aulast=Salamone&amp;rft.aufirst=JD&amp;rft.au=Correa%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4450094&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPezzeFeldon2004" class="citation journal cs1">Pezze MA, Feldon J (December 2004). "Mesolimbic dopaminergic pathways in fear conditioning". <i>Progress in Neurobiology</i>. <b>74</b> (5): 301–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pneurobio.2004.09.004">10.1016/j.pneurobio.2004.09.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15582224">15582224</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:36091832">36091832</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Neurobiology&amp;rft.atitle=Mesolimbic+dopaminergic+pathways+in+fear+conditioning&amp;rft.volume=74&amp;rft.issue=5&amp;rft.pages=301-20&amp;rft.date=2004-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A36091832%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15582224&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pneurobio.2004.09.004&amp;rft.aulast=Pezze&amp;rft.aufirst=MA&amp;rft.au=Feldon%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Pleasure_system-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pleasure_system_18-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBerridgeKringelbach2015" class="citation journal cs1">Berridge KC, Kringelbach ML (May 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4425246">"Pleasure systems in the brain"</a>. <i>Neuron</i>. <b>86</b> (3): 646–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuron.2015.02.018">10.1016/j.neuron.2015.02.018</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4425246">4425246</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25950633">25950633</a>. <q>To summarize: the emerging realization that many diverse pleasures share overlapping brain substrates; better neuroimaging maps for encoding human pleasure in orbitofrontal cortex; identification of hotspots and separable brain mechanisms for generating ‘liking’ and ‘wanting’ for the same reward; identification of larger keyboard patterns of generators for desire and dread within NAc, with multiple modes of function; and the realization that dopamine and most ‘pleasure electrode’ candidates for brain hedonic generators probably did not cause much pleasure after all.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuron&amp;rft.atitle=Pleasure+systems+in+the+brain&amp;rft.volume=86&amp;rft.issue=3&amp;rft.pages=646-64&amp;rft.date=2015-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4425246%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25950633&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuron.2015.02.018&amp;rft.aulast=Berridge&amp;rft.aufirst=KC&amp;rft.au=Kringelbach%2C+ML&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4425246&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBerridgeKringelbach2013" class="citation journal cs1">Berridge KC, Kringelbach ML (June 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3644539">"Neuroscience of affect: brain mechanisms of pleasure and displeasure"</a>. <i>Current Opinion in Neurobiology</i>. <b>23</b> (3): 294–303. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.conb.2013.01.017">10.1016/j.conb.2013.01.017</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3644539">3644539</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23375169">23375169</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Neurobiology&amp;rft.atitle=Neuroscience+of+affect%3A+brain+mechanisms+of+pleasure+and+displeasure&amp;rft.volume=23&amp;rft.issue=3&amp;rft.pages=294-303&amp;rft.date=2013-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3644539%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23375169&amp;rft_id=info%3Adoi%2F10.1016%2Fj.conb.2013.01.017&amp;rft.aulast=Berridge&amp;rft.aufirst=KC&amp;rft.au=Kringelbach%2C+ML&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3644539&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNestler2020" class="citation book cs1">Nestler EJ (2020). <a rel="nofollow" class="external text" href="https://www.worldcat.org/oclc/1191071328"><i>Molecular neuropharmacology a foundation for clinical neuroscience</i></a>. Paul J. Kenny, Scott J. Russo, Anne, MD Schaefer (Fourth&#160;ed.). New York. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-260-45691-2" title="Special:BookSources/978-1-260-45691-2"><bdi>978-1-260-45691-2</bdi></a>. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/1191071328">1191071328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Molecular+neuropharmacology+a+foundation+for+clinical+neuroscience&amp;rft.place=New+York&amp;rft.edition=Fourth&amp;rft.date=2020&amp;rft_id=info%3Aoclcnum%2F1191071328&amp;rft.isbn=978-1-260-45691-2&amp;rft.aulast=Nestler&amp;rft.aufirst=EJ&amp;rft_id=https%3A%2F%2Fwww.worldcat.org%2Foclc%2F1191071328&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBerridgeKringelbach2015" class="citation journal cs1">Berridge KC, Kringelbach ML (May 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4425246">"Pleasure systems in the brain"</a>. <i>Neuron</i>. <b>86</b> (3): 646–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuron.2015.02.018">10.1016/j.neuron.2015.02.018</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4425246">4425246</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25950633">25950633</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuron&amp;rft.atitle=Pleasure+systems+in+the+brain&amp;rft.volume=86&amp;rft.issue=3&amp;rft.pages=646-64&amp;rft.date=2015-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4425246%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25950633&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuron.2015.02.018&amp;rft.aulast=Berridge&amp;rft.aufirst=KC&amp;rft.au=Kringelbach%2C+ML&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4425246&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Reward_system_components_and_structure-specific_functions-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-Reward_system_components_and_structure-specific_functions_22-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTaylorLewisOlive2013" class="citation journal cs1">Taylor SB, Lewis CR, Olive MF (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3931688">"The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans"</a>. <i>Substance Abuse and Rehabilitation</i>. <b>4</b>: 29–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FSAR.S39684">10.2147/SAR.S39684</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3931688">3931688</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24648786">24648786</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Substance+Abuse+and+Rehabilitation&amp;rft.atitle=The+neurocircuitry+of+illicit+psychostimulant+addiction%3A+acute+and+chronic+effects+in+humans&amp;rft.volume=4&amp;rft.pages=29-43&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3931688%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24648786&amp;rft_id=info%3Adoi%2F10.2147%2FSAR.S39684&amp;rft.aulast=Taylor&amp;rft.aufirst=SB&amp;rft.au=Lewis%2C+CR&amp;rft.au=Olive%2C+MF&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3931688&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Striatal_efferents,_afferents,_and_colocalized_receptors_in_dMSNs_and_iMSNs-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-Striatal_efferents,_afferents,_and_colocalized_receptors_in_dMSNs_and_iMSNs_23-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFYagerGarciaWunschFerguson2015" class="citation journal cs1">Yager LM, Garcia AF, Wunsch AM, Ferguson SM (August 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4523218">"The ins and outs of the striatum: role in drug addiction"</a>. <i>Neuroscience</i>. <b>301</b>: 529–41. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuroscience.2015.06.033">10.1016/j.neuroscience.2015.06.033</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4523218">4523218</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26116518">26116518</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroscience&amp;rft.atitle=The+ins+and+outs+of+the+striatum%3A+role+in+drug+addiction&amp;rft.volume=301&amp;rft.pages=529-41&amp;rft.date=2015-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4523218%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26116518&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuroscience.2015.06.033&amp;rft.aulast=Yager&amp;rft.aufirst=LM&amp;rft.au=Garcia%2C+AF&amp;rft.au=Wunsch%2C+AM&amp;rft.au=Ferguson%2C+SM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4523218&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid21270784-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid21270784_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid21270784_24-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMaiaFrank2011" class="citation journal cs1">Maia TV, Frank MJ (February 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4408000">"From reinforcement learning models to psychiatric and neurological disorders"</a>. <i>Nature Neuroscience</i>. <b>14</b> (2): 154–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnn.2723">10.1038/nn.2723</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4408000">4408000</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21270784">21270784</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Neuroscience&amp;rft.atitle=From+reinforcement+learning+models+to+psychiatric+and+neurological+disorders&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=154-62&amp;rft.date=2011-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408000%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21270784&amp;rft_id=info%3Adoi%2F10.1038%2Fnn.2723&amp;rft.aulast=Maia&amp;rft.aufirst=TV&amp;rft.au=Frank%2C+MJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBeuckeSepulcreTalukdarLinnman2013" class="citation journal cs1">Beucke JC, Sepulcre J, Talukdar T, Linnman C, Zschenderlein K, Endrass T,  et&#160;al. (June 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamapsychiatry.2013.173">"Abnormally high degree connectivity of the orbitofrontal cortex in obsessive-compulsive disorder"</a>. <i>JAMA Psychiatry</i>. <b>70</b> (6): 619–29. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamapsychiatry.2013.173">10.1001/jamapsychiatry.2013.173</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23740050">23740050</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Psychiatry&amp;rft.atitle=Abnormally+high+degree+connectivity+of+the+orbitofrontal+cortex+in+obsessive-compulsive+disorder&amp;rft.volume=70&amp;rft.issue=6&amp;rft.pages=619-29&amp;rft.date=2013-06&amp;rft_id=info%3Adoi%2F10.1001%2Fjamapsychiatry.2013.173&amp;rft_id=info%3Apmid%2F23740050&amp;rft.aulast=Beucke&amp;rft.aufirst=JC&amp;rft.au=Sepulcre%2C+J&amp;rft.au=Talukdar%2C+T&amp;rft.au=Linnman%2C+C&amp;rft.au=Zschenderlein%2C+K&amp;rft.au=Endrass%2C+T&amp;rft.au=Kaufmann%2C+C&amp;rft.au=Kathmann%2C+N&amp;rft_id=%2F%2Fdoi.org%2F10.1001%252Fjamapsychiatry.2013.173&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMaiaCooneyPeterson2008" class="citation journal cs1">Maia TV, Cooney RE, Peterson BS (1 January 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3079445">"The neural bases of obsessive-compulsive disorder in children and adults"</a>. <i>Development and Psychopathology</i>. <b>20</b> (4): 1251–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS0954579408000606">10.1017/S0954579408000606</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3079445">3079445</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18838041">18838041</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Development+and+Psychopathology&amp;rft.atitle=The+neural+bases+of+obsessive-compulsive+disorder+in+children+and+adults&amp;rft.volume=20&amp;rft.issue=4&amp;rft.pages=1251-83&amp;rft.date=2008-01-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3079445%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18838041&amp;rft_id=info%3Adoi%2F10.1017%2FS0954579408000606&amp;rft.aulast=Maia&amp;rft.aufirst=TV&amp;rft.au=Cooney%2C+RE&amp;rft.au=Peterson%2C+BS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3079445&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-5-ht_da-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-5-ht_da_27-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAdellBortolozziDíaz-MataixSantana2010" class="citation book cs1">Adell A, Bortolozzi A, Díaz-Mataix L, Santana N, Celada P, Artigas F (January 2010). "Serotonin interaction with other transmitter systems.".  In Muller CP, Jacobs B (eds.). <i>Handbook of Behavioral Neuroscience</i>. Vol.&#160;21. London: Academic. pp.&#160;259-276 (262–264). <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-12-374634-4" title="Special:BookSources/978-0-12-374634-4"><bdi>978-0-12-374634-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Serotonin+interaction+with+other+transmitter+systems.&amp;rft.btitle=Handbook+of+Behavioral+Neuroscience&amp;rft.place=London&amp;rft.pages=259-276+%28262-264%29&amp;rft.pub=Academic&amp;rft.date=2010-01&amp;rft.isbn=978-0-12-374634-4&amp;rft.aulast=Adell&amp;rft.aufirst=A&amp;rft.au=Bortolozzi%2C+A&amp;rft.au=D%C3%ADaz-Mataix%2C+L&amp;rft.au=Santana%2C+N&amp;rft.au=Celada%2C+P&amp;rft.au=Artigas%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-cholinergic-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-cholinergic_28-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShinAdroverWessAlvarez2015" class="citation journal cs1">Shin JH, Adrover MF, Wess J, Alvarez VA (June 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4491757">"Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>112</b> (26): 8124–9. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2015PNAS..112.8124S">2015PNAS..112.8124S</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1073%2Fpnas.1508846112">10.1073/pnas.1508846112</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4491757">4491757</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26080439">26080439</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Muscarinic+regulation+of+dopamine+and+glutamate+transmission+in+the+nucleus+accumbens&amp;rft.volume=112&amp;rft.issue=26&amp;rft.pages=8124-9&amp;rft.date=2015-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4491757%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26080439&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1508846112&amp;rft_id=info%3Abibcode%2F2015PNAS..112.8124S&amp;rft.aulast=Shin&amp;rft.aufirst=JH&amp;rft.au=Adrover%2C+MF&amp;rft.au=Wess%2C+J&amp;rft.au=Alvarez%2C+VA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4491757&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-endocannabinoid_inhibition-29"><span class="mw-cite-backlink">^ <a href="#cite_ref-endocannabinoid_inhibition_29-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-endocannabinoid_inhibition_29-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-endocannabinoid_inhibition_29-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMelisPistis2007" class="citation journal cs1">Melis M, Pistis M (December 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2644494">"Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?"</a>. <i>Current Neuropharmacology</i>. <b>5</b> (4): 268–77. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F157015907782793612">10.2174/157015907782793612</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2644494">2644494</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19305743">19305743</a>. <q>Thus, it is conceivable that low levels of CB1 receptors are located on glutamatergic and GABAergic terminals impinging on DA neurons [127, 214], where they can fine-tune the release of inhibitory and excitatory neurotransmitter and regulate DA neuron firing.<br />Consistently, in vitro electrophysiological experiments from independent laboratories have provided evidence of CB1 receptor localization on glutamatergic and GABAergic axon terminals in the VTA and SNc.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neuropharmacology&amp;rft.atitle=Endocannabinoid+signaling+in+midbrain+dopamine+neurons%3A+more+than+physiology%3F&amp;rft.volume=5&amp;rft.issue=4&amp;rft.pages=268-77&amp;rft.date=2007-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2644494%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19305743&amp;rft_id=info%3Adoi%2F10.2174%2F157015907782793612&amp;rft.aulast=Melis&amp;rft.aufirst=M&amp;rft.au=Pistis%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2644494&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-da_regulation-30"><span class="mw-cite-backlink">^ <a href="#cite_ref-da_regulation_30-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-da_regulation_30-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-da_regulation_30-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-da_regulation_30-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-da_regulation_30-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-da_regulation_30-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-da_regulation_30-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMorikawaPaladini2011" class="citation journal cs1">Morikawa H, Paladini CA (December 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3221882">"Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms"</a>. <i>Neuroscience</i>. <b>198</b>: 95–111. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.neuroscience.2011.08.023">10.1016/j.neuroscience.2011.08.023</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3221882">3221882</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21872647">21872647</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroscience&amp;rft.atitle=Dynamic+regulation+of+midbrain+dopamine+neuron+activity%3A+intrinsic%2C+synaptic%2C+and+plasticity+mechanisms&amp;rft.volume=198&amp;rft.pages=95-111&amp;rft.date=2011-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3221882%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21872647&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuroscience.2011.08.023&amp;rft.aulast=Morikawa&amp;rft.aufirst=H&amp;rft.au=Paladini%2C+CA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3221882&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Noradrenergic_modulation_of_DA_neurons_-_2014_review-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Noradrenergic_modulation_of_DA_neurons_-_2014_review_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Noradrenergic_modulation_of_DA_neurons_-_2014_review_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChandlerWaterhouseGao2014" class="citation journal cs1">Chandler DJ, Waterhouse BD, Gao WJ (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4033238">"New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons"</a>. <i>Frontiers in Neural Circuits</i>. <b>8</b>: 53. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffncir.2014.00053">10.3389/fncir.2014.00053</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4033238">4033238</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24904299">24904299</a>. <q>It has been shown that electrical stimulation of LC results in an excitation followed by a brief inhibition of midbrain dopamine (DA) neurons through an α1 receptor dependent mechanism (Grenhoff et al., 1993).</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neural+Circuits&amp;rft.atitle=New+perspectives+on+catecholaminergic+regulation+of+executive+circuits%3A+evidence+for+independent+modulation+of+prefrontal+functions+by+midbrain+dopaminergic+and+noradrenergic+neurons&amp;rft.volume=8&amp;rft.pages=53&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4033238%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24904299&amp;rft_id=info%3Adoi%2F10.3389%2Ffncir.2014.00053&amp;rft.aulast=Chandler&amp;rft.aufirst=DJ&amp;rft.au=Waterhouse%2C+BD&amp;rft.au=Gao%2C+WJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4033238&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Cannabinoid-Orexin_systemic_cross-talk-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Cannabinoid-Orexin_systemic_cross-talk_32-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFloresMaldonadoBerrendero2013" class="citation journal cs1">Flores A, Maldonado R, Berrendero F (December 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3868890">"Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far"</a>. <i>Frontiers in Neuroscience</i>. <b>7</b>: 256. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnins.2013.00256">10.3389/fnins.2013.00256</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3868890">3868890</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24391536">24391536</a>. <q>Direct CB1-HcrtR1 interaction was first proposed in 2003 (Hilairet et al., 2003). Indeed, a 100-fold increase in the potency of hypocretin-1 to activate the ERK signaling was observed when CB1 and HcrtR1 were co-expressed&#160;...  In this study, a higher potency of hypocretin-1 to regulate CB1-HcrtR1 heteromer compared with the HcrtR1-HcrtR1 homomer was reported (Ward et al., 2011b). These data provide unambiguous identification of CB1-HcrtR1 heteromerization, which has a substantial functional impact.&#160;... The existence of a cross-talk between the hypocretinergic and endocannabinoid systems is strongly supported by their partially overlapping anatomical distribution and common role in several physiological and pathological processes. However, little is known about the mechanisms underlying this interaction.&#160;... Acting as a retrograde messenger, endocannabinoids modulate the glutamatergic excitatory and GABAergic inhibitory synaptic inputs into the dopaminergic neurons of the VTA and the glutamate transmission in the NAc. Thus, the activation of CB1 receptors present on axon terminals of GABAergic neurons in the VTA inhibits GABA transmission, removing this inhibitory input on dopaminergic neurons (Riegel and Lupica, 2004). Glutamate synaptic transmission in the VTA and NAc, mainly from neurons of the PFC, is similarly modulated by the activation of CB1 receptors (Melis et al., 2004).</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neuroscience&amp;rft.atitle=Cannabinoid-hypocretin+cross-talk+in+the+central+nervous+system%3A+what+we+know+so+far&amp;rft.volume=7&amp;rft.pages=256&amp;rft.date=2013-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3868890%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24391536&amp;rft_id=info%3Adoi%2F10.3389%2Ffnins.2013.00256&amp;rft.aulast=Flores&amp;rft.aufirst=A&amp;rft.au=Maldonado%2C+R&amp;rft.au=Berrendero%2C+F&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3868890&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span><br />&#160;&#8226;&#32;<a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868890/figure/F1/">Figure 1: Schematic of brain CB1 expression and orexinergic neurons expressing OX1 (HcrtR1) or OX2 (HcrtR2)</a><br />&#160;&#8226;&#32;<a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868890/figure/F2/">Figure 2: Synaptic signaling mechanisms in cannabinoid and orexin systems</a><br />&#160;&#8226;&#32;<a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868890/figure/F3/">Figure 3: Schematic of brain pathways involved in food intake</a></span>
</li>
<li id="cite_note-pmid19815001-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19815001_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19815001_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAston-JonesSmithSartorMoorman2010" class="citation journal cs1">Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA (February 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2819557">"Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction"</a>. <i>Brain Research</i>. <b>1314</b>: 74–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.brainres.2009.09.106">10.1016/j.brainres.2009.09.106</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2819557">2819557</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19815001">19815001</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Research&amp;rft.atitle=Lateral+hypothalamic+orexin%2Fhypocretin+neurons%3A+A+role+in+reward-seeking+and+addiction&amp;rft.volume=1314&amp;rft.pages=74-90&amp;rft.date=2010-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819557%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19815001&amp;rft_id=info%3Adoi%2F10.1016%2Fj.brainres.2009.09.106&amp;rft.aulast=Aston-Jones&amp;rft.aufirst=G&amp;rft.au=Smith%2C+RJ&amp;rft.au=Sartor%2C+GC&amp;rft.au=Moorman%2C+DE&amp;rft.au=Massi%2C+L&amp;rft.au=Tahsili-Fahadan%2C+P&amp;rft.au=Richardson%2C+KA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2819557&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
<li id="cite_note-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Human_heterodimers:_OX1–OX2_OX1–CB1_OX2–CB1_35-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJänttiMandrikaKukkonen2014" class="citation journal cs1">Jäntti MH, Mandrika I, Kukkonen JP (March 2014). "Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors". <i>Biochemical and Biophysical Research Communications</i>. <b>445</b> (2): 486–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bbrc.2014.02.026">10.1016/j.bbrc.2014.02.026</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24530395">24530395</a>. <q>Orexin receptor subtypes readily formed homo- and hetero(di)mers, as suggested by significant BRET signals. CB1 receptors formed homodimers, and they also heterodimerized with both orexin receptors.&#160;... In conclusion, orexin receptors have a significant propensity to make homo- and heterodi-/oligomeric complexes. However, it is unclear whether this affects their signaling. As orexin receptors efficiently signal via endocannabinoid production to CB1 receptors, dimerization could be an effective way of forming signal complexes with optimal cannabinoid concentrations available for cannabinoid receptors.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochemical+and+Biophysical+Research+Communications&amp;rft.atitle=Human+orexin%2Fhypocretin+receptors+form+constitutive+homo-+and+heteromeric+complexes+with+each+other+and+with+human+CB1+cannabinoid+receptors&amp;rft.volume=445&amp;rft.issue=2&amp;rft.pages=486-90&amp;rft.date=2014-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbrc.2014.02.026&amp;rft_id=info%3Apmid%2F24530395&amp;rft.aulast=J%C3%A4ntti&amp;rft.aufirst=MH&amp;rft.au=Mandrika%2C+I&amp;rft.au=Kukkonen%2C+JP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ADopaminergic+pathways" class="Z3988"></span></span>
</li>
</ol></div>
<div class="navbox-styles nomobile"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-labelledby="Neurotransmitter_systems" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Neurotransmitter_systems" title="Template:Neurotransmitter systems"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Neurotransmitter_systems" title="Template talk:Neurotransmitter systems"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Neurotransmitter_systems&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Neurotransmitter_systems" style="font-size:114%;margin:0 4em"><a href="/wiki/Neurotransmitter#Brain_neurotransmitter_systems" title="Neurotransmitter">Neurotransmitter systems</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Acetylcholine" title="Acetylcholine">Acetylcholine</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Nucleus_basalis_of_Meynert" class="mw-redirect" title="Nucleus basalis of Meynert">Nucleus basalis of Meynert</a> → <a href="/wiki/Neocortex" title="Neocortex">Neocortex</a></li></ul>
<ul><li><a href="/wiki/Septal_nuclei" class="mw-redirect" title="Septal nuclei">Septal nuclei</a> (<a href="/wiki/Medial_septal_nucleus" title="Medial septal nucleus">Medial septal nucleus</a>) → <a href="/wiki/Fornix_of_the_brain" class="mw-redirect" title="Fornix of the brain">Fornix</a> → <a href="/wiki/Hippocampus" title="Hippocampus">Hippocampus</a></li></ul>
<ul><li><a href="/wiki/Striatum" title="Striatum">Striatum</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Biogenic_amine" title="Biogenic amine">BA</a>/<a href="/wiki/Monoamine_neurotransmitter" title="Monoamine neurotransmitter">M</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a class="mw-selflink selflink">Dopaminergic pathways</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Mesocortical_pathway" title="Mesocortical pathway">Mesocortical pathway</a>: <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">Ventral tegmental area</a> → <a href="/wiki/Prefrontal_cortices" class="mw-redirect" title="Prefrontal cortices">Prefrontal cortices</a></li></ul>
<ul><li><a href="/wiki/Mesolimbic_pathway" title="Mesolimbic pathway">Mesolimbic pathway</a>: <a href="/wiki/Ventral_tegmental_area" title="Ventral tegmental area">Ventral tegmental area</a> → <a href="/wiki/Nucleus_accumbens" title="Nucleus accumbens">Nucleus accumbens</a> and <a href="/wiki/Olfactory_tubercle" title="Olfactory tubercle">olfactory tubercle</a></li></ul>
<ul><li><a href="/wiki/Nigrostriatal_pathway" title="Nigrostriatal pathway">Nigrostriatal pathway</a>: <a href="/wiki/Substantia_nigra_pars_compacta" class="mw-redirect" title="Substantia nigra pars compacta">Substantia nigra pars compacta</a> → <a href="/wiki/Caudate_nucleus" title="Caudate nucleus">Caudate nucleus</a> and <a href="/wiki/Putamen" title="Putamen">putamen</a></li></ul>
<ul><li><a href="/wiki/Tuberoinfundibular_pathway" title="Tuberoinfundibular pathway">Tuberoinfundibular pathway</a>: Hypothalamus (<a href="/wiki/Infundibular_nucleus" class="mw-redirect" title="Infundibular nucleus">Infundibular nucleus</a>) → Pituitary gland (<a href="/wiki/Median_eminence" title="Median eminence">Median eminence</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Norepinephrine" title="Norepinephrine">Norepinephrine</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Locus_coeruleus" title="Locus coeruleus">Locus coeruleus</a></li>
<li><a href="/wiki/Lateral_tegmental_field" class="mw-redirect" title="Lateral tegmental field">Lateral tegmental field</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Serotonin_pathways" class="mw-redirect" title="Serotonin pathways">Serotonin pathways</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Raphe_nuclei" title="Raphe nuclei">Raphe nuclei</a></li>
<li><a href="/wiki/Anterior_raphespinal_tract" title="Anterior raphespinal tract">Anterior raphespinal tract</a></li>
<li><a href="/wiki/Lateral_raphespinal_tract" title="Lateral raphespinal tract">Lateral raphespinal tract</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Amino_acid" title="Amino acid">AA</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Aspartic_acid" title="Aspartic acid">Aspartate</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Climbing_fiber" title="Climbing fiber">Climbing fibers</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">GABA</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Globus_pallidus" title="Globus pallidus">Globus pallidus</a></li>
<li><a href="/wiki/Rostromedial_tegmental_nucleus" title="Rostromedial tegmental nucleus">Rostromedial tegmental nucleus</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Glycine" title="Glycine">Glycine</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Renshaw_cell" title="Renshaw cell">Renshaw cells</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Glutamic_acid" title="Glutamic acid">Glutamate</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Thalamus" title="Thalamus">Thalamus</a></li>
<li><a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">Subthalamic nucleus</a></li>
<li><a href="/wiki/Globus_pallidus" title="Globus pallidus">Globus pallidus</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div></div>